Clostridium botulinum neurotoxin vaccine: Start Phase I

DynPort, a subsidiary of Computer Sciences Corp. (El Segundo, Calif.), began an open-label, U.S. Phase I trial in 33 healthy volunteers, 11 of whom already have been enrolled. The vaccine has Fast Tra...